http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP088217-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate 2008-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f96f51b5214f8089f8961d580d6cb2b
publicationDate 2008-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EC-SP088217-A
titleOfInvention FORMS OF CRYSTAL DELTA AND EYESILON MESILATE IMATINIB
abstract The invention relates to the delta and epsilon crystal form of the methanesulfonic acid addition salt of 4- (4-methyl-piperazin-1-yl-methyl) -N- [4-methyl-3- ( 4- (pyridin-3-yl) -pyrimidin-2-yl-amino) -phenyl] -benzamide (the compound of the formula I, see below), to certain processes for its preparation, to pharmaceutical compositions containing these forms crystal, and for use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, and for use as an intermediary or for the preparation of pharmaceutical preparations for use in diagnostic methods or for the therapeutic treatment of blood animals Hot, especially humans.
priorityDate 2005-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407378349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291

Total number of triples: 19.